Company Filing History:
Years Active: 2021
Title: Fred Elustondo: Innovator in Pyrimidinone Derivatives
Introduction
Fred Elustondo is an inventor based in Great Britain, known for his contributions to the field of medicinal chemistry. His work primarily focuses on the development of compounds that target specific biological pathways, particularly in the context of cancer treatment.
Latest Patents
Fred Elustondo holds a patent titled "Preparation And Uses Of Pyrimidinone Derivatives." This invention relates to compounds that function as inhibitors of cell division cycle 7 (Cdc7) kinase enzyme activity. The compounds are defined by a specific formula, which includes various components such as X, R1, R2, and n. The invention also encompasses processes for preparing these compounds, pharmaceutical compositions that include them, and their applications in treating proliferative disorders, including cancer.
Career Highlights
Throughout his career, Fred Elustondo has focused on innovative approaches to drug development. His research has contributed to a better understanding of the mechanisms involved in cell division and how they can be manipulated for therapeutic purposes.
Collaborations
Fred has collaborated with Emma L Carswell, working together to advance their research in the field of medicinal chemistry. Their partnership has led to significant insights and developments in the area of Cdc7 kinase inhibitors.
Conclusion
Fred Elustondo's work in the preparation and use of pyrimidinone derivatives highlights his commitment to advancing medical science. His innovative contributions have the potential to impact the treatment of various proliferative disorders, including cancer.